Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 3
Submit an article Journal homepage
135
Views
15
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Outcome of adults with acute lymphocytic leukemia in second or subsequent complete remission

Hagop M. KantarjianDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
,
Deborah ThomasDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Farhad RavandiDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Stefan FaderlDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Guillermo Garcia-ManeroDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Jianquin ShanDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Sherry PierceDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Jorge CortesDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
&
Susan O'BrienDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
 show all
Pages 475-480 | Received 10 Sep 2009, Accepted 21 Nov 2009, Published online: 18 Jan 2010

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shira Dinner, Daniel Lee & Michaela Liedtke. (2014) Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia. Leukemia & Lymphoma 55:8, pages 1715-1724.
Read now

Articles from other publishers (14)

Adam C Robinson, Bernard L Marini, Kristen M Pettit & Anthony J Perissinotti. (2019) Successful use of blinatumomab in a patient with acute lymphoblastic leukemia and severe hepatic dysfunction. Journal of Oncology Pharmacy Practice 26:1, pages 200-205.
Crossref
Hagop Kantarjian & Susan O’Brien. (2019) Poor Penetration of Existing Effective Chemoimmunotherapy for the Treatment of Older Patients With Newly Diagnosed Acute Lymphocytic Leukemia (ALL) or Refractory/Relapsed ALL. Journal of Oncology Practice 15:2, pages 77-79.
Crossref
Yanhui Liu, Fei Xue, Yin Zhang, Pingchong Lei, Zhen Wang, Zunmin Zhu & Kai Sun. (2017) N1-guanyl-1,7-diaminoheptane enhances the chemosensitivity of acute lymphoblastic leukemia cells to vincristine through inhibition of eif5a-2 activation. Anti-Cancer Drugs 28:10, pages 1097-1105.
Crossref
Connie Lee Batlevi, Eri Matsuki, Renier J. Brentjens & Anas Younes. (2015) Novel immunotherapies in lymphoid malignancies. Nature Reviews Clinical Oncology 13:1, pages 25-40.
Crossref
Deborah Saltman, Arie Barlev, Divyagiri Seshagiri, Ioannis Katsoulis, Vincent Lin & Beth Barber. (2015) Management and treatment of relapsed or refractory Ph(−) B-precursor ALL: a web-based, double-blind survey of EU clinicians. BMC Cancer 15:1.
Crossref
Ofir Wolach & Richard M. Stone. (2015) Blinatumomab for the Treatment of Philadelphia Chromosome–Negative, Precursor B-cell Acute Lymphoblastic Leukemia. Clinical Cancer Research 21:19, pages 4262-4269.
Crossref
Maksim Mamonkin, Rayne H. Rouce, Haruko Tashiro & Malcolm K. Brenner. (2015) A T-cell–directed chimeric antigen receptor for the selective treatment of T-cell malignancies. Blood 126:8, pages 983-992.
Crossref
Michaela Liedtke, Tamara Dunn, Shira Dinner, Steven E. Coutré, Caroline Berube, Jason Gotlib, Samit Patel & Bruno Medeiros. (2014) Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia. Leukemia Research 38:12, pages 1441-1445.
Crossref
Enrico De Astis, Marino Clavio, Anna Maria Raiola, Anna Ghiso, Fabio Guolo, Paola Minetto, Federica Galaverna, Maurizio Miglino, Carmen Di Grazia, Filippo Ballerini, Carlo Marani, Giordana Pastori, Laura Mitscheunig, Fabio Cruciani, Davide Lovera, Riccardo Varaldo, Chiara Ghiggi, Roberto Massimo Lemoli, Andrea Bacigalupo & Marco Gobbi. (2014) Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia. Annals of Hematology 93:12, pages 2011-2018.
Crossref
Cheng Zhang, Xi Zhang & Xing-Hua Chen. (2013) Interleukin-2 priming chemotherapy: A strategy to improve the remission of refractory/relapsed T cell acute lymphoblastic leukemia. Medical Hypotheses 81:5, pages 878-880.
Crossref
Elena Liew, Eshetu G. Atenafu, Aaron D. Schimmer, Karen W.L. Yee, Andre C. Schuh, Mark D. Minden, Vikas Gupta & Joseph M. Brandwein. (2012) Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimen. Leukemia Research 36:12, pages 1517-1520.
Crossref
Denise M. Oliansky, Richard A. Larson, Daniel Weisdorf, Hildy Dillon, Thomas A. Ratko, Donna Wall, Philip L. McCarthyJr.Jr. & Theresa Hahn. (2012) The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Update of the 2006 Evidence-Based Review. Biology of Blood and Marrow Transplantation 18:1, pages 18-36.e6.
Crossref
Josep-Maria Ribera. (2011) Advances in acute lymphoblastic leukemia in adults. Current Opinion in Oncology 23:6, pages 692-699.
Crossref
Farshid Dayyani, Sarah Schellhorn Mougalian, Kiran Naqvi, Jianqin Shan, Farhad Ravandi, Jorge Cortes, Jeffrey Weinberg, Elias Jabbour, Stefan Faderl, William Wierda, Deborah Thomas, Susan O'Brien, Sherry Pierce, Hagop Kantarjian & Guillermo Garcia‐Manero. (2011) Prediction model for mortality after intracranial hemorrhage in patients with leukemia. American Journal of Hematology 86:7, pages 546-549.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.